Position in FLGT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$220,179
+$49,572 QoQ
Shares Held
10,730
0.0% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#79
of 142 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FLGT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026MACKENZIE FINANCIAL CORP holds $567,039,905 across 20 Diagnostics & Research names. FLGT ranks #20 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
1,044,132 | $198,886,263 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
331,992 | $166,447,509 | |
| 3 | DGX |
Quest Diagnostics Inc
|
333,295 | $70,641,875 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
44,162 | $23,248,643 | |
| 5 | CSTL |
Castle Biosciences Inc
|
793,507 | $18,925,141 | |
| 6 | NTRA |
Natera, Inc.
|
53,116 | $14,418,338 | |
| 7 | A |
Agilent Technologies, Inc.
|
90,705 | $12,048,345 | |
| 8 | LH |
Labcorp Holdings Inc.
|
35,179 | $9,850,120 |
All Filings in FLGT
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $220,179 | 10,730 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $170,607 | 10,730 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $315,923 | 12,026 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $274,703 | 12,155 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $217,387 | 10,935 | Shares | Sole | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||